abstract |
□ The present invention relates to a compound of formula (I) suitable for use as a hepatitis C virus (HCV) NS5B polymerase inhibitor, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treatment or Prevention of HCV infection and its use for inhibiting HCV viral replication and/or virus production in cell-based systems. |